These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3539979)

  • 1. Gonadotropin-independent precocious puberty ("testotoxicosis"): influence of maturational status on response to ketoconazole.
    Holland FJ; Kirsch SE; Selby R
    J Clin Endocrinol Metab; 1987 Feb; 64(2):328-33. PubMed ID: 3539979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy.
    Holland FJ; Fishman L; Bailey JD; Fazekas AT
    N Engl J Med; 1985 Apr; 312(16):1023-8. PubMed ID: 2984563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases.
    Rosenthal SM; Grumbach MM; Kaplan SL
    J Clin Endocrinol Metab; 1983 Sep; 57(3):571-9. PubMed ID: 6223935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring the treatment of precocious puberty with a GnRH-analog (buserelin): comparison of the GnRH-test with nocturnal pulsatility of LH, testosterone and 17-beta-estradiol].
    Radetti G; Pasquino B; Castellan C; Gentili L; Mengarda G
    Pediatr Med Chir; 1991; 13(5):471-4. PubMed ID: 1788106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole.
    Almeida MQ; Brito VN; Lins TS; Guerra-Junior G; de Castro M; Antonini SR; Arnhold IJ; Mendonca BB; Latronico AC
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):93-8. PubMed ID: 18088394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyproterone acetate therapy on gonadotropin response to synthetic luteinizing hormone-releasing hormone (LRH) in girls with idiopathic precocious puberty.
    Angeli A; Boccuzzi G; Bisbocci D; Fonzo D; Frajria R; DeSanctis C; Ceresa F
    J Clin Endocrinol Metab; 1976 Mar; 42(3):551-60. PubMed ID: 767354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
    Comite F; Pescovitz OH; Rieth KG; Dwyer AJ; Hench K; McNemar A; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Nov; 59(5):888-92. PubMed ID: 6434587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary-gonadal axis in both sexes.
    Latronico AC; Lins TS; Brito VN; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):609-13. PubMed ID: 11106922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy.
    Feuillan PP; Jones JV; Barnes KM; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4036-8. PubMed ID: 11095429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating mutations in the luteinizing hormone receptor gene: a human model of non-follicle-stimulating hormone-dependent inhibin production and germ cell maturation.
    Soriano-Guillen L; Mitchell V; Carel JC; Barbet P; Roger M; Lahlou N
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3041-7. PubMed ID: 16684832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum melatonin in central precocious puberty is lower than in age-matched prepubertal children.
    Waldhauser F; Boepple PA; Schemper M; Mansfield MJ; Crowley WF
    J Clin Endocrinol Metab; 1991 Oct; 73(4):793-6. PubMed ID: 1909703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
    Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
    J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin.
    Laue L; Jones J; Barnes KM; Cutler GB
    J Clin Endocrinol Metab; 1993 Jan; 76(1):151-5. PubMed ID: 8421081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge.
    Ghai K; Rosenfield RL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1336-40. PubMed ID: 8200935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone-induced luteinizing hormone secretion in normal, precocious, and delayed puberty.
    Petraglia F; Bernasconi S; Iughetti L; Loche S; Romanini F; Facchinetti F; Marcellini C; Genazzani AR
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1112-6. PubMed ID: 3531220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.